Induced Pluripotent Stem Cells Production Global Market Report 2022: Sector to Reach $2.8 Billion by 2030 at a 9.2% CAGR
Retrieved on:
Monday, January 9, 2023
Severe acute respiratory syndrome coronavirus 2, Blastomere, Degenerative disease, Cell culture, Stroke, Regenerative medicine, SARS, International Diabetes Federation, Heart, Biotechnology, Drug discovery, Therapy, Potency (pharmacology), IDF, Research, Drug development, Destiny, ESC, COVID-19, USD, Growth, Patient, Embryonic stem cell, B cell, Process, Conditional sentence, Business analysis, Chapter Five, Diabetes, Marketspace, Prevalence, Cell, Renewable energy, Pharmaceutical industry, Fine chemical, Workflow
The global induced pluripotent stem cells production market size is estimated to reach USD 2.8 billion by 2030.
Key Points:
- The global induced pluripotent stem cells production market size is estimated to reach USD 2.8 billion by 2030.
- The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market.
- Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs.
- The key factors driving the revenue growth are the developed healthcare infrastructure, the prevalence of chronic diseases, the presence of strategic business models and funds by supportive government
Chapter 4 Induced Pluripotent Stem Cells (Ipscs) Production Market: Process Business Analysis
Chapter 5 Induced Pluripotent Stem Cells (Ipscs) Production Market: Workflow Business Analysis
Chapter 6 Induced Pluripotent Stem Cells (Ipscs) Production Market: Product Business Analysis
Chapter 7 Induced Pluripotent Stem Cells (Ipscs) Production Market: Application Business Analysis
Chapter 8 Induced Pluripotent Stem Cells (Ipscs) Production Market: End-User Business Analysis
Chapter 9 Induced Pluripotent Stem Cells (Ipscs) Production Market: Regional Business Analysis